Advertisement

Topics

Tyme Technologies, Inc. Company Profile

04:38 EDT 19th June 2018 | BioPortfolio

Tyme, Inc. is a pharmaceutical company focused on discovering and developing highly targeted cancer therapeutics for a broad range of oncology indications. Tyme, Inc. is the originator of what it believes to be a novel, proprietary treatment regimen consisting of a rationally-designed combination of therapeutic agents aimed at exploiting the aberrant metabolic characteristics of cancer cells as well as activating the endogenous immune response against tumors. Tyme, Inc.'s approach is hypothesized to permit selective elimination of cancer cells, while simultaneously improving patients' well-being, particularly with respect to pain severity and functional independence.


News Articles [216 Associated News Articles listed on BioPortfolio]

Tyme Technologies (TYME) Presents At 10th Annual Biotech Showcase 2018 - Slideshow

Tyme Technologies (TYME) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow

Tyme Technologies (TYME) Presents At RBC Capital Markets Global Healthcare Conference - Slideshow

Tyme Technologies Announces Offering of Common Stock

NEW YORK, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME) (the “Company”), a clinical-stage biotechnology company developing cancer therapeutics, today announced that ...

Tyme Technologies Appoints Tommy G. Thompson to Board of Directors

NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage biotechnology company developing cancer therapeutics, today announced the appointment of former...

Tyme Technologies Announces Closing of Public Offering of Common Stock

NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME) (“Tyme” or the “Company”) announced today that, on March 6, 2018, it closed its underwritten public off...

Tyme Technologies Announces Pricing of its Offering of 9 Million Shares of Common Stock

NEW YORK, March 01, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME) (the “Company”) announced today that it has priced its underwritten public offering of 9 million shares of i...

Tyme Technologies, Inc. Announces Participation at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco on April 8-10, 2018

NEW YORK, March 29, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME) (“Tyme” or the “Company”) announced today that it will be featured as a presenting company at the H. C....

PubMed Articles [336 Associated PubMed Articles listed on BioPortfolio]

Three-dimensional Technologies in Orthopedics.

New 3-dimensional digital technologies are revolutionizing orthopedic clinical practice, allowing structures of any complexity to be manufactured in just hours. Such technologies can make surgery for ...

'Omic' technologies as a helpful tool in radioecological research.

This article presents a brief review of the modern 'omic' technologies, namely genomics, epigenomics, transcriptomics, proteomics, and metabolomics, as well as the examples of their possible use in ra...

On the Cusp of a Healthcare Revolution: BME Technologies Have the Potential to ?Transform Our World?

Of the key technologies listed as "ready to propel industries and transform our world" in the 2017 report Top 50 Emerging Technologies: Growth Opportunities of Strategic Imperative, most fall under th...

The state of knowledge on technologies and their use for fall detection: A scoping review.

Globally, populations are aging with increasing life spans. The normal aging process and the resulting disabilities increase fall risks. Falls are an important cause of injury, loss of independence an...

Economic evaluations of eHealth technologies: A systematic review.

Innovations in eHealth technologies have the potential to help older adults live independently, maintain their quality of life, and to reduce their health system dependency and health care expenditure...

Clinical Trials [393 Associated Clinical Trials listed on BioPortfolio]

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Testing Latest Version of NidekRS3000Adv

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whet...

Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies

The proposed project will address the measurement and ramifications of out-of-home mobility problems in various orthopedic disorders in an innovative way, using advanced tracking technolog...

Online Peer Networked Collaborative Learning for Managing Depressive Symptoms

The mission of this project is to develop novel systems of care that can provide efficacious, scalable, cost-effective, participant friendly technology assisted behavioral interventions (T...

Companies [1257 Associated Companies listed on BioPortfolio]

Tyme Technologies, Inc.

Tyme, Inc. is a pharmaceutical company focused on discovering and developing highly targeted cancer therapeutics for a broad range of oncology indications. Tyme, Inc. is the origi...

Tyme, Inc.

Tyme is a pharmaceutical company focused on discovering and developing highly targeted cancer therapeutics for a broad range of oncology indications. Tyme is the originator of wha...

Tyme Technologies, Inc.

Tyme Technologies Inc.

LVL Technologies, Inc.

LVL Technologies, Inc. was founded by Dr. Dustin Freckleton and Nithin Rajan with a mission of bringing the accuracy of medical device technologies to the consumer wearables marke...

More Information about "Tyme Technologies, Inc." on BioPortfolio

We have published hundreds of Tyme Technologies, Inc. news stories on BioPortfolio along with dozens of Tyme Technologies, Inc. Clinical Trials and PubMed Articles about Tyme Technologies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tyme Technologies, Inc. Companies in our database. You can also find out about relevant Tyme Technologies, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record